Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000982

Drug Information
SynonymsAC1L18OI; WLN: T56 BM DN FN HNJ IZ; nchembio.2007.56-comp15; 1H-Purine, 6-amino; CCRIS 2556; 9H-Purine, 1,6-dihydro-6-imino-; KBio1_001575; DB00173; Spectrum3_000616; NCGC00094856-02; 2p8n; cMAP_000085; 6-Amino-3H-purine; Adenine-8-14C; BSPBio_002152; MolPort-004-758-264; 3,6-Dihydro-6-iminopurine; NCI60_000998; MolPort-001-785-186; 1jys; 1H-Purin-6-amine (9CI); KBio3_003040; 42911-33-1; D000225; 6-Amino-1H-purine; HMS2092K20; 6-Aminopurine; 1nli; 1,6-Dihydro-6-Imnopurine; NSC 14666; EINECS 200-796-1; Purine, 6-amino-; KBio2_001586; 6379C0E0-C1BB-4087-96C5-1DE281B8EA4C; Spectrum2_000583; NCGC00094856-03; Vitamin B 4; D00034; 1H-Purin-6-amine; I07-0071; MolPort-004-758-265; purine, 6; Adenine [JAN]; KBioSS_002571; 5426-35-7; AC1Q52Y5; MolPort-004-759-679; SPBio_000426; TL806440; KBioSS_001586; 2pqj; 66224-65-5; AC-2028; ADE; A8626_SIGMA; MolPort-004-758-262; Oprea1_057274; 4, Vitamin B; 6-Aminopurine; Vitamin B4; MolPort-004-758-653; Adenine (8CI); AD2; Spectrum5_000542; B 4, Vitamin; A2786_SIGMA; Leucon (TN); InChI=1/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10; DivK1c_006631; KBio2_005130; 6-Amino-9H-purine; C00147; Pedatisectine B; 520-75-2; KBioGR_002447; SpecPlus_000535; I14-7794; TL8005091; A5665_SIGMA; I06-0527; NSC14666; MolPort-004-758-263; KBio2_002562; 9H-Purin-6-amine; AI3-50679; NCGC00094856-01; KBio2_007698; 1,6-Dihydro-6-iminopurine; A0149; KBio2_006722; CID190; 22051-90-7; FT-0082877; MolPort-001-785-762; Adeninimine; 42911-34-2; KBio3_001652; CHEMBL226345; STOCK1N-48520; ZINC00000882; nchembio.186-comp107; ANE; 1wei; bmse000060; STK387542; AB1004094; ALBB-005925; 7H-Purin-6-amine; Leuco-4; Spectrum4_001891; USAF CB-18; Spectrum_001106; AKOS000118903; Vitamin-?B4; Vitamin B4; MLS001066342; AC1Q52XT; SMR000471871; Adenine (JAN/USP); HMS1921I14; A2426_SIGMA; SPECTRUM1500807; adenine; Adenin; KBioGR_002562; adenine-ring; KBio2_004154; CHEBI:16708; LS-15058; 6-Amino-7H-purine; 2'-DEOXY-ADENOSINE-3'-5'-DIPHOSPHATE; 1H-Purine, 6-amino-; SDCCGMLS-0066584.P001; 73-24-5    
IndicationDietary shortageApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassDietary supplement    
CAS NumberCAS 73-24-5
PubChem Compound IDCID 190.    
PubChem Substance IDSID 2101.    
Ref 1Drug information of Adenine, 2008 To Reference
Ref 2E.coli DNA Adenine Methyltransferase: Intra-Site Processivity and Substrate-Induced Dimerization and Activation. Biochemistry. 2009 Jul 6. [Epub ahead of print] To Reference
Ref 3Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages. Mol Biochem Parasitol. 2006 Jul;148(1):24-30. Epub 2006 Mar 15. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543